Robert G. Shepler - 18 Nov 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Robert G. Shepler, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
18 Nov 2021
Net transactions value
+$441,005
Form type
4
Filing time
18 Nov 2021, 20:08:53 UTC
Previous filing
25 May 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Purchase $182,505 +15,000 $12.17 15,000 18 Nov 2021 Direct F1
transaction AKYA Common Stock Purchase $258,500 +20,000 +133% $12.92 35,000 18 Nov 2021 Direct F2
holding AKYA Common Stock 214,592 18 Nov 2021 Robert G. Shepler Separate Property Trust of 2008
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $11.85-$12.75. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within the range set forth herein.
F2 Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $12.85-$13.00. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within the range set forth herein.